EP2976070 - ANTI-INFLAMMATORY SYNERGISTIC COMBINATIONS OF ASTAXANTHIN WITH LYCOPENE AND CARNOSIC ACID [Right-click to bookmark this link] | |||
Former [2016/04] | ASTAXANTHIN ANTI-INFLAMMATORY SYNERGISTIC COMBINATIONS | ||
[2020/50] | Status | No opposition filed within time limit Status updated on 18.03.2022 Database last updated on 04.11.2024 | |
Former | The patent has been granted Status updated on 09.04.2021 | ||
Former | Grant of patent is intended Status updated on 25.11.2020 | ||
Former | Examination is in progress Status updated on 14.09.2018 | Most recent event Tooltip | 06.09.2024 | Lapse of the patent in a contracting state New state(s): MT | published on 09.10.2024 [2024/41] | Applicant(s) | For all designated states Lycored Ltd. P.O. Box 320 84102 Beer Sheva / IL | [2021/19] |
Former [2016/04] | For all designated states Lycored Ltd. P.O. Box 320 84102 Beer Sheva / IL | Inventor(s) | 01 /
LEVY, Rachel 8 Livna St. 84965 Omer / IL | 02 /
HADAD, Nurit P.O. Box 320 84102 Beer Sheva / IL | 03 /
SEDLOV, Tanya 27 Levin Kipnis St. 84496 Beer Sheva / IL | 04 /
ZELKHA, Morris 4 Givati St. 52232 Ramat Gan / IL | [2016/04] | Representative(s) | Boult Wade Tennant LLP Salisbury Square House 8 Salisbury Square London EC4Y 8AP / GB | [2021/19] |
Former [2016/04] | Wichmann, Hendrik Wuesthoff & Wuesthoff Patentanwälte PartG mbB Schweigerstraße 2 81541 München / DE | Application number, filing date | 14768070.6 | 13.03.2014 | [2016/04] | WO2014IL50272 | Priority number, date | US201361803191P | 19.03.2013 Original published format: US 201361803191 P | [2016/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014147610 | Date: | 25.09.2014 | Language: | EN | [2014/39] | Type: | A1 Application with search report | No.: | EP2976070 | Date: | 27.01.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.09.2014 takes the place of the publication of the European patent application. | [2016/04] | Type: | B1 Patent specification | No.: | EP2976070 | Date: | 12.05.2021 | Language: | EN | [2021/19] | Search report(s) | International search report - published on: | IL | 25.09.2014 | (Supplementary) European search report - dispatched on: | EP | 10.10.2016 | Classification | IPC: | A61K31/122, A61K31/01, A61K31/192, A61P29/00 | [2016/04] | CPC: |
A61K31/122 (EP,US);
A23L33/105 (EP,US);
A61K31/01 (EP,US);
A61K31/015 (EP,US);
A61K31/047 (EP,US);
A61K31/192 (EP,US);
A61K31/355 (EP,US);
A61K36/81 (US);
A61K9/0053 (US);
A61P29/00 (EP);
A61P43/00 (EP);
A23V2002/00 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/04] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | ENTZÜNDUNGSHEMMENDE SYNERGISTISCHE KOMBINATIONEN ENTHALTEND ASTAXANTHIN, LYCOPIN UND CARNOSINSÄURE | [2020/50] | English: | ANTI-INFLAMMATORY SYNERGISTIC COMBINATIONS OF ASTAXANTHIN WITH LYCOPENE AND CARNOSIC ACID | [2020/50] | French: | COMBINAISONS ANTI-INFLAMMATOIRES SYNERGIQUES D'ASTAXANTHINE, DE LYCOPÈNE ET D'ACIDE CARNOSIQUE | [2020/50] |
Former [2016/04] | ENTZÜNDUNGSHEMMENDE SYNERGISTISCHE ASTAXANTHINKOMBINATIONEN | ||
Former [2016/04] | ASTAXANTHIN ANTI-INFLAMMATORY SYNERGISTIC COMBINATIONS | ||
Former [2016/04] | COMBINAISONS SYNERGIQUES D'ASTAXANTHINE ET D'ANTI-INFLAMMATOIRE | Entry into regional phase | 21.09.2015 | National basic fee paid | 21.09.2015 | Search fee paid | 21.09.2015 | Designation fee(s) paid | 21.09.2015 | Examination fee paid | Examination procedure | 21.09.2015 | Examination requested [2016/04] | 20.04.2017 | Amendment by applicant (claims and/or description) | 12.09.2018 | Despatch of a communication from the examining division (Time limit: M04) | 11.01.2019 | Reply to a communication from the examining division | 28.10.2019 | Despatch of a communication from the examining division (Time limit: M04) | 30.01.2020 | Reply to a communication from the examining division | 26.11.2020 | Communication of intention to grant the patent | 31.03.2021 | Fee for grant paid | 31.03.2021 | Fee for publishing/printing paid | 31.03.2021 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 12.09.2018 | Opposition(s) | 15.02.2022 | No opposition filed within time limit [2022/16] | Fees paid | Renewal fee | 25.03.2016 | Renewal fee patent year 03 | 10.03.2017 | Renewal fee patent year 04 | 13.03.2018 | Renewal fee patent year 05 | 04.03.2019 | Renewal fee patent year 06 | 09.03.2020 | Renewal fee patent year 07 | 16.03.2021 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 13.03.2014 | AL | 12.05.2021 | AT | 12.05.2021 | CY | 12.05.2021 | CZ | 12.05.2021 | DK | 12.05.2021 | EE | 12.05.2021 | FI | 12.05.2021 | HR | 12.05.2021 | LT | 12.05.2021 | LV | 12.05.2021 | MC | 12.05.2021 | MK | 12.05.2021 | MT | 12.05.2021 | NL | 12.05.2021 | RO | 12.05.2021 | RS | 12.05.2021 | SE | 12.05.2021 | SI | 12.05.2021 | SK | 12.05.2021 | SM | 12.05.2021 | TR | 12.05.2021 | BG | 12.08.2021 | NO | 12.08.2021 | GR | 13.08.2021 | IS | 12.09.2021 | PT | 13.09.2021 | [2024/41] |
Former [2024/29] | HU | 13.03.2014 | |
AL | 12.05.2021 | ||
AT | 12.05.2021 | ||
CY | 12.05.2021 | ||
CZ | 12.05.2021 | ||
DK | 12.05.2021 | ||
EE | 12.05.2021 | ||
FI | 12.05.2021 | ||
HR | 12.05.2021 | ||
LT | 12.05.2021 | ||
LV | 12.05.2021 | ||
MC | 12.05.2021 | ||
MK | 12.05.2021 | ||
NL | 12.05.2021 | ||
RO | 12.05.2021 | ||
RS | 12.05.2021 | ||
SE | 12.05.2021 | ||
SI | 12.05.2021 | ||
SK | 12.05.2021 | ||
SM | 12.05.2021 | ||
TR | 12.05.2021 | ||
BG | 12.08.2021 | ||
NO | 12.08.2021 | ||
GR | 13.08.2021 | ||
IS | 12.09.2021 | ||
PT | 13.09.2021 | ||
Former [2024/22] | HU | 13.03.2014 | |
AL | 12.05.2021 | ||
AT | 12.05.2021 | ||
CY | 12.05.2021 | ||
CZ | 12.05.2021 | ||
DK | 12.05.2021 | ||
EE | 12.05.2021 | ||
FI | 12.05.2021 | ||
HR | 12.05.2021 | ||
LT | 12.05.2021 | ||
LV | 12.05.2021 | ||
MC | 12.05.2021 | ||
MK | 12.05.2021 | ||
NL | 12.05.2021 | ||
RO | 12.05.2021 | ||
RS | 12.05.2021 | ||
SE | 12.05.2021 | ||
SI | 12.05.2021 | ||
SK | 12.05.2021 | ||
SM | 12.05.2021 | ||
BG | 12.08.2021 | ||
NO | 12.08.2021 | ||
GR | 13.08.2021 | ||
IS | 12.09.2021 | ||
PT | 13.09.2021 | ||
Former [2024/20] | HU | 13.03.2014 | |
AL | 12.05.2021 | ||
AT | 12.05.2021 | ||
CY | 12.05.2021 | ||
CZ | 12.05.2021 | ||
DK | 12.05.2021 | ||
EE | 12.05.2021 | ||
FI | 12.05.2021 | ||
HR | 12.05.2021 | ||
LT | 12.05.2021 | ||
LV | 12.05.2021 | ||
MC | 12.05.2021 | ||
NL | 12.05.2021 | ||
RO | 12.05.2021 | ||
RS | 12.05.2021 | ||
SE | 12.05.2021 | ||
SI | 12.05.2021 | ||
SK | 12.05.2021 | ||
SM | 12.05.2021 | ||
BG | 12.08.2021 | ||
NO | 12.08.2021 | ||
GR | 13.08.2021 | ||
IS | 12.09.2021 | ||
PT | 13.09.2021 | ||
Former [2024/18] | HU | 13.03.2014 | |
AL | 12.05.2021 | ||
AT | 12.05.2021 | ||
CZ | 12.05.2021 | ||
DK | 12.05.2021 | ||
EE | 12.05.2021 | ||
FI | 12.05.2021 | ||
HR | 12.05.2021 | ||
LT | 12.05.2021 | ||
LV | 12.05.2021 | ||
MC | 12.05.2021 | ||
NL | 12.05.2021 | ||
RO | 12.05.2021 | ||
RS | 12.05.2021 | ||
SE | 12.05.2021 | ||
SI | 12.05.2021 | ||
SK | 12.05.2021 | ||
SM | 12.05.2021 | ||
BG | 12.08.2021 | ||
NO | 12.08.2021 | ||
GR | 13.08.2021 | ||
IS | 12.09.2021 | ||
PT | 13.09.2021 | ||
Former [2022/47] | AL | 12.05.2021 | |
AT | 12.05.2021 | ||
CZ | 12.05.2021 | ||
DK | 12.05.2021 | ||
EE | 12.05.2021 | ||
FI | 12.05.2021 | ||
HR | 12.05.2021 | ||
LT | 12.05.2021 | ||
LV | 12.05.2021 | ||
MC | 12.05.2021 | ||
NL | 12.05.2021 | ||
RO | 12.05.2021 | ||
RS | 12.05.2021 | ||
SE | 12.05.2021 | ||
SI | 12.05.2021 | ||
SK | 12.05.2021 | ||
SM | 12.05.2021 | ||
BG | 12.08.2021 | ||
NO | 12.08.2021 | ||
GR | 13.08.2021 | ||
IS | 12.09.2021 | ||
PT | 13.09.2021 | ||
Former [2022/29] | AL | 12.05.2021 | |
AT | 12.05.2021 | ||
CZ | 12.05.2021 | ||
DK | 12.05.2021 | ||
EE | 12.05.2021 | ||
FI | 12.05.2021 | ||
HR | 12.05.2021 | ||
LT | 12.05.2021 | ||
LV | 12.05.2021 | ||
NL | 12.05.2021 | ||
RO | 12.05.2021 | ||
RS | 12.05.2021 | ||
SE | 12.05.2021 | ||
SI | 12.05.2021 | ||
SK | 12.05.2021 | ||
SM | 12.05.2021 | ||
BG | 12.08.2021 | ||
NO | 12.08.2021 | ||
GR | 13.08.2021 | ||
IS | 12.09.2021 | ||
PT | 13.09.2021 | ||
Former [2022/26] | AL | 12.05.2021 | |
AT | 12.05.2021 | ||
CZ | 12.05.2021 | ||
DK | 12.05.2021 | ||
EE | 12.05.2021 | ||
FI | 12.05.2021 | ||
HR | 12.05.2021 | ||
LT | 12.05.2021 | ||
LV | 12.05.2021 | ||
NL | 12.05.2021 | ||
RO | 12.05.2021 | ||
RS | 12.05.2021 | ||
SE | 12.05.2021 | ||
SK | 12.05.2021 | ||
SM | 12.05.2021 | ||
BG | 12.08.2021 | ||
NO | 12.08.2021 | ||
GR | 13.08.2021 | ||
IS | 12.09.2021 | ||
PT | 13.09.2021 | ||
Former [2022/23] | AT | 12.05.2021 | |
CZ | 12.05.2021 | ||
DK | 12.05.2021 | ||
EE | 12.05.2021 | ||
FI | 12.05.2021 | ||
HR | 12.05.2021 | ||
LT | 12.05.2021 | ||
LV | 12.05.2021 | ||
NL | 12.05.2021 | ||
RO | 12.05.2021 | ||
RS | 12.05.2021 | ||
SE | 12.05.2021 | ||
SK | 12.05.2021 | ||
SM | 12.05.2021 | ||
BG | 12.08.2021 | ||
NO | 12.08.2021 | ||
GR | 13.08.2021 | ||
IS | 12.09.2021 | ||
PT | 13.09.2021 | ||
Former [2022/10] | AT | 12.05.2021 | |
CZ | 12.05.2021 | ||
DK | 12.05.2021 | ||
EE | 12.05.2021 | ||
FI | 12.05.2021 | ||
HR | 12.05.2021 | ||
LT | 12.05.2021 | ||
LV | 12.05.2021 | ||
NL | 12.05.2021 | ||
RO | 12.05.2021 | ||
RS | 12.05.2021 | ||
SE | 12.05.2021 | ||
SK | 12.05.2021 | ||
SM | 12.05.2021 | ||
BG | 12.08.2021 | ||
NO | 12.08.2021 | ||
GR | 13.08.2021 | ||
PT | 13.09.2021 | ||
IS | 22.12.2021 | ||
Former [2022/09] | AT | 12.05.2021 | |
CZ | 12.05.2021 | ||
DK | 12.05.2021 | ||
FI | 12.05.2021 | ||
HR | 12.05.2021 | ||
LT | 12.05.2021 | ||
LV | 12.05.2021 | ||
NL | 12.05.2021 | ||
RO | 12.05.2021 | ||
RS | 12.05.2021 | ||
SE | 12.05.2021 | ||
SK | 12.05.2021 | ||
SM | 12.05.2021 | ||
BG | 12.08.2021 | ||
NO | 12.08.2021 | ||
GR | 13.08.2021 | ||
IS | 12.09.2021 | ||
PT | 13.09.2021 | ||
Former [2022/08] | AT | 12.05.2021 | |
CZ | 12.05.2021 | ||
DK | 12.05.2021 | ||
FI | 12.05.2021 | ||
HR | 12.05.2021 | ||
LT | 12.05.2021 | ||
LV | 12.05.2021 | ||
NL | 12.05.2021 | ||
RS | 12.05.2021 | ||
SE | 12.05.2021 | ||
SM | 12.05.2021 | ||
BG | 12.08.2021 | ||
NO | 12.08.2021 | ||
GR | 13.08.2021 | ||
IS | 12.09.2021 | ||
PT | 13.09.2021 | ||
Former [2022/07] | AT | 12.05.2021 | |
FI | 12.05.2021 | ||
HR | 12.05.2021 | ||
LT | 12.05.2021 | ||
LV | 12.05.2021 | ||
NL | 12.05.2021 | ||
RS | 12.05.2021 | ||
SE | 12.05.2021 | ||
SM | 12.05.2021 | ||
BG | 12.08.2021 | ||
NO | 12.08.2021 | ||
GR | 13.08.2021 | ||
IS | 12.09.2021 | ||
PT | 13.09.2021 | ||
Former [2022/04] | AT | 12.05.2021 | |
FI | 12.05.2021 | ||
HR | 12.05.2021 | ||
LT | 12.05.2021 | ||
LV | 12.05.2021 | ||
NL | 12.05.2021 | ||
RS | 12.05.2021 | ||
SE | 12.05.2021 | ||
BG | 12.08.2021 | ||
NO | 12.08.2021 | ||
GR | 13.08.2021 | ||
IS | 12.09.2021 | ||
PT | 13.09.2021 | ||
Former [2021/51] | AT | 12.05.2021 | |
FI | 12.05.2021 | ||
HR | 12.05.2021 | ||
LT | 12.05.2021 | ||
LV | 12.05.2021 | ||
RS | 12.05.2021 | ||
SE | 12.05.2021 | ||
BG | 12.08.2021 | ||
NO | 12.08.2021 | ||
GR | 13.08.2021 | ||
IS | 12.09.2021 | ||
PT | 13.09.2021 | ||
Former [2021/50] | AT | 12.05.2021 | |
FI | 12.05.2021 | ||
HR | 12.05.2021 | ||
LT | 12.05.2021 | ||
LV | 12.05.2021 | ||
SE | 12.05.2021 | ||
BG | 12.08.2021 | ||
NO | 12.08.2021 | ||
GR | 13.08.2021 | ||
PT | 13.09.2021 | ||
Former [2021/49] | AT | 12.05.2021 | |
FI | 12.05.2021 | ||
HR | 12.05.2021 | ||
LT | 12.05.2021 | ||
LV | 12.05.2021 | ||
SE | 12.05.2021 | ||
BG | 12.08.2021 | ||
NO | 12.08.2021 | ||
GR | 13.08.2021 | ||
Former [2021/47] | AT | 12.05.2021 | |
FI | 12.05.2021 | ||
LT | 12.05.2021 | ||
BG | 12.08.2021 | ||
Former [2021/46] | AT | 12.05.2021 | |
FI | 12.05.2021 | ||
LT | 12.05.2021 | Documents cited: | Search | [A]WO2010082205 (LYCORED LTD [IL], et al) [A] 1-15 * the whole document * | [XI] - Anonymous, "Higher Nature Astaxanthine and Blackcurrant Capsules Pack of 90: Amazon.co.uk: Health & Personal Care", (20070226), pages 1 - 6, URL: https://www.amazon.co.uk/dp/B000NRVW2U?_encoding=UTF8&isInIframe=0&n=65801031&ref_=dp_proddesc_0&s=drugstore&showDetailProductDesc=1#product-description_feature_div, (20160922), XP055304798 [X] 1,2,6-9 * the whole document * [I] 3-5 | [XI] - Dorie Greenspan, "Salmon with Tomatoes & Rosemary", (20110723), pages 1 - 3, URL: http://communitytable.parade.com/30359/doriegreenspan/salmon-with-tomatoes-rosemary/, (20160922), XP055304820 [X] 1,2,6-8 * the whole document * [I] 3-5 | International search | [X]WO2004052351 (DSM IP ASSETS BV [NL], et al); | [X]WO2009007975 (LYCORED LTD [IL], et al); | [Y] - HADAD N ET AL., "The synergistic anti-inflammatory effects of lycopene, lutein, ?- carotene, and carnosic acid combinations via redox-based inhibition of NF-?B signaling.", FREE RADIC BIOL MED., vol. 53, no. 7, (20121001), pages 1381 - 91, URL: http://www.sciencedirect.com/science/article/pii/50891584912004728, (20140618), XP055279495 DOI: http://dx.doi.org/10.1016/j.freeradbiomed.2012.07.078 | [Y] - LEE SJ ET AL., "Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing I(kappa)B kinase-dependent NF-kappaB activation.", MOL CELLS., vol. 16, no. 1, (20030831), pages 97 - 105, URL: http://www.molcells.org/journal/view.html?year=2003&volume=16&number=1&spage=97, (20140618), XP055279498 | [A] - PALOZZA P ET AL., "Tomato lycopene and inflammatory cascade: basic interactions and clinical implications.", CURR MED CHEM. 2010, vol. 17, no. 23, (20100831), pages 2547 - 63, URL: http://www.eurekaselect.com/71902/article, (20140616), XP055279499 DOI: http://dx.doi.org/10.2174/092986710791556041 | Examination | - Ramses B Toma ET AL, "Lycopene content in raw tomato varieties and tomato products", Journal of Foodservice, doi:10.1111/j.1745-4506.2008.00094.x, (20080401), pages 127 - 132, URL: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1745-4506.2008.00094.x, XP055504862 DOI: http://dx.doi.org/10.1111/j.1745-4506.2008.00094.x | - Ademoyegun Olufemi Temitope ET AL, "Fresh Produce 2009 Global Science Books Lycopene Content in Tomatoes (Lycopersicon esculentum Mill): Effect of Thermal Heat and its Health Benefits", (20090101), URL: http://www.globalsciencebooks.info/Online/GSBOnline/images/0906/FP_3(1)/FP_3(1)40-43o.pdf, (20180905), XP055504863 | - Pratik M. Choksi ET AL, "A Review on Lycopene-Extraction, Purification, Stability and Applications", INTERNATIONAL JOURNAL OF FOOD PROPERTIES, US, (20070425), vol. 10, no. 2, doi:10.1080/10942910601052699, ISSN 1094-2912, pages 289 - 298, XP055504864 DOI: http://dx.doi.org/10.1080/10942910601052699 | by applicant | WO2010082205 | US5837311 | - RAFI M.M. et al., Mol Nutr Food Res., (20070300), vol. 51, no. 3, pages 333 - 40 | - CHOI, J.S., Nutrition, (20060600), vol. 22, no. 6, pages 668 - 71 | - RAFI, M.M. et al., J Food Sci., (20070100), vol. 72, no. 1, pages 069 - 74 | - FINGL et al., The Pharmacological Basis of Therapeutics, Mack Publishing Co., (19750000), page l | - Current Protocols in Molecular Biology, (19940000), vol. I-III | - T. W. GRAHAM SOLOMONSCRAIG FRYHLE, Organic Chemistry | DE19951009955 |